Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Smart Life Sciences Manufacturing Market Poised To Hit $59.21 Billion By 2030 With A 15.9% CAGR
The smart life sciences manufacturing market has witnessed rapid expansion in recent years. Its value is projected to rise from $28.59 billion in 2025 to $32.83 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.8%. The market’s historical growth can be attributed to factors such as the increasing complexity of life sciences manufacturing processes, heightened regulatory scrutiny on product quality, the expansion of pharmaceutical and biopharma production capacity, the early adoption of automation technologies, and the growing demand for manufacturing traceability.
The smart life sciences manufacturing market is projected to experience substantial expansion in the coming years, with its value anticipated to reach $59.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.9%. This projected growth stems from several factors, including heightened investments in intelligent pharmaceutical factories, the increasing uptake of digital twin technologies, the broadening scope of personalized medicine production, the expanding incorporation of AI-powered quality analytics, and a heightened emphasis on the transparency and robustness of supply chains. Key developments expected during this forecast timeframe encompass the increasing implementation of digital manufacturing execution systems, the greater integration of IoT-enabled production monitoring, the expanding application of sophisticated data analytics for process enhancement, the wider deployment of automation and robotics within pharmaceutical manufacturing, and a stronger emphasis on adhering to regulatory standards and maintaining quality control.
Get A Free Sample Report With In-Depth Market Insights:
Smart Life Sciences Manufacturing Market Demand Drivers Opening New Revenue Streams
The increasing need for personalized medicine is projected to drive the expansion of the smart life sciences manufacturing market in the future. This involves a healthcare and medical treatment methodology where medical decisions, practices, interventions, and therapies are customized for each individual patient. The escalating call for personalized medicine is compelling the life sciences sector to integrate smart manufacturing technologies and processes, facilitating the efficient, precise, and adaptable production of tailored pharmaceuticals and therapies, thereby enhancing treatment results. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit, indicated that in 2023, the FDA sanctioned 16 novel personalized treatments for rare disease patients, an increase from six in 2022. Among these newly approved personalized treatments for 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the heightened demand for personalized medicine is fueling the growth of the smart life sciences manufacturing market.
Smart Life Sciences Manufacturing Market Segments: Where Is Growth Concentrated?
The smart life sciences manufacturing market covered in this report is segmented –
1) By Component: Solution, Services
2) By Technology: Internet of Things (IoT), Artificial Intelligence, Cybersecurity, Big Data, Other Technologies
3) By Application: Pharma, Bio-Pharma, Medical Device
Subsegments:
1) By Solution: Manufacturing Execution Systems (MES), Quality Management Systems (QMS), Automation and Control, Data Analytics And Reporting
2) By Services: Consulting Services, Integration And Implementation, Maintenance and Support
Smart Life Sciences Manufacturing Market Trends Powering Strategic Industry Growth
Leading market participants are directing their efforts towards creating advanced AI (artificial intelligence) medical technologies to maintain their standing. AI-driven innovations are essential in smart life science for analyzing and interpreting vast data volumes, streamlining operations, and enabling more personalized engagement. For instance, in May 2023, Google Cloud Platform LLC, a US-based technology company, introduced two new AI-powered solutions aimed at accelerating drug discovery and precision medicine. This innovative suite of tools can assist researchers in identifying new drugs more swiftly and efficiently. Additionally, these tools can help enhance the accuracy of drug development and reduce the cost involved in bringing novel drugs to market. Furthermore, this has the potential to hasten the expansion of new drug development and improve the lives of patients.
Smart Life Sciences Manufacturing Market Key Participants And Competitive Landscape
Major companies operating in the smart life sciences manufacturing market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Novartis AG, Merck and Co Inc, Sanofi S A, GlaxoSmithKline plc, AstraZeneca plc, Bristol Myers Squibb, Eli Lilly and Company, AbbVie Inc, Amgen Inc, Gilead Sciences Inc, Biogen Inc, Takeda Pharmaceutical Company Limited, Bayer AG, Boehringer Ingelheim, Novo Nordisk A S, Teva Pharmaceutical Industries Ltd, CSL Limited
View The Full Smart Life Sciences Manufacturing Market Report:
Smart Life Sciences Manufacturing Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the smart life sciences manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart life sciences manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
